Literature DB >> 17056846

What is the best evidence based management of neonatal abstinence syndrome?

N Nandakumar, V S Sankar.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17056846      PMCID： PMC2672769          DOI： 10.1136/adc.2006.095166

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  4 in total

1.  Assessment and treatment of abstinence in the infant of the drug-dependent mother.

Authors:  L P Finnegan; R E Kron; J F Connaughton; J P Emich
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-07

2.  A survey of the management of neonatal opiate withdrawal in England and Wales.

Authors:  C L Morrison; C Siney
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

Review 3.  Current management of the neonatal abstinence syndrome: a critical analysis of the evidence.

Authors:  J G Theis; P Selby; Y Ikizler; G Koren
Journal:  Biol Neonate       Date:  1997

Review 4.  Opiate treatment for opiate withdrawal in newborn infants.

Authors:  D A Osborn; M J Cole; H E Jeffery
Journal:  Cochrane Database Syst Rev       Date:  2002
  4 in total
  6 in total

1.  Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.

Authors:  Walter K Kraft; Kevin Dysart; Jay S Greenspan; Eric Gibson; Karol Kaltenbach; Michelle E Ehrlich
Journal:  Addiction       Date:  2010-10-06       Impact factor: 6.526

2.  Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011.

Authors:  S W Patrick; H C Kaplan; M Passarella; M M Davis; S A Lorch
Journal:  J Perinatol       Date:  2014-06-12       Impact factor: 2.521

Review 3.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

4.  Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.

Authors:  Walter K Kraft; Eric Gibson; Kevin Dysart; Vidula S Damle; Jennifer L Larusso; Jay S Greenspan; David E Moody; Karol Kaltenbach; Michelle E Ehrlich
Journal:  Pediatrics       Date:  2008-08-11       Impact factor: 7.124

5.  Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure.

Authors:  Jason R Wiles; Barbara Isemann; Laura P Ward; Alexander A Vinks; Henry Akinbi
Journal:  J Pediatr       Date:  2014-06-16       Impact factor: 4.406

6.  Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: a retrospective cohort study.

Authors:  C E Witt; K E Rudd; P Bhatraju; F P Rivara; S E Hawes; N S Weiss
Journal:  J Perinatol       Date:  2017-07-06       Impact factor: 2.521
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.